This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sommer, F. Articles by Lohoff, M. Search for Related Content PubMed PubMed Citation Articles by Sommer, F. Articles by Lohoff, M.

 Previous Article  |  Next Article 

Infection and Immunity, February 2004, p. 1029-1035, Vol. 72, No. 2
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.2.1029-1035.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Systemic Th1 Immunization of Mice against Helicobacter pylori Infection with CpG Oligodeoxynucleotides as Adjuvants Does Not Protect from Infection but Enhances Gastritis

Institut fuer Medizinische Mikrobiologie und Hygiene, University of Marburg, Marburg,¹ Institut fuer Pathologie, University of Erlangen, Erlangen, Germany²

Received 19 July 2003/ Returned for modification 2 September 2003/ Accepted 6 November 2003

Recent reports have suggested that oral vaccination of mice against Helicobacter pylori is dependent on a Th1-mediated immune response. However, oral vaccination in mice neither induces sterilizing immunity nor leads to complete protection from disease. Therefore, in this study we investigated whether a systemic subcutaneous immunization against H. pylori by using CpG oligodeoxynucleotides as a Th1 adjuvant could achieve protection in a mouse model of H. pylori infection. CpG oligodeoxynucleotides are known for their ability to induce nearly entirely Th1-biased immune responses and may be approved for human use in future. Immunization of mice with H. pylori lysate and CpG induced a strong local and systemic Th1 immune response. Despite this strong Th1 response, mice were not protected from infection with H. pylori yet had a 10-fold reduction in the number of H. pylori in the gastric mucosa compared to nonimmunized mice. Of note, reduction of the bacterial density in immunized mice was accompanied by a significantly enhanced gastritis. Hence, systemic Th1 immunization of mice, even though being able to reduce the bacterial load in the stomach, is associated with aggravated pathology.

Editor: F. C. Fang

This article has been cited by other articles:

• Mitchell, P., Germain, C., Fiori, P. L., Khamri, W., Foster, G. R., Ghosh, S., Lechler, R. I., Bamford, K. B., Lombardi, G. (2007). Chronic Exposure to Helicobacter pylori Impairs Dendritic Cell Function and Inhibits Th1 Development. Infect. Immun. 75: 810-819 [Abstract] [Full Text]  
• Kusters, J. G., van Vliet, A. H. M., Kuipers, E. J. (2006). Pathogenesis of Helicobacter pylori Infection. Clin. Microbiol. Rev. 19: 449-490 [Abstract] [Full Text]  
• Chui, S. Y., Clay, T. M., Lyerly, H. K., Morse, M. A. (2005). The Development of Therapeutic and Preventive Vaccines for Gastric Cancer and Helicobacter pylori. Cancer Epidemiol. Biomarkers Prev. 14: 1883-1889 [Abstract] [Full Text]  
• Salaun, L., Ayraud, S., Saunders, N. J. (2005). Phase variation mediated niche adaptation during prolonged experimental murine infection with Helicobacter pylori. Microbiology 151: 917-923 [Abstract] [Full Text]